| Ident. | Authors (with country if any) | Title |
|---|
| 000102 (2019) |
Laura Rodriguez ; Pilar Blanco-Lobo ; Emma C. Reilly [États-Unis] ; Tatsuya Maehigashi ; Aitor Nogales ; Andrew Smith [États-Unis] ; David J. Topham [États-Unis] ; Stephen Dewhurst ; Baek Kim [Corée du Sud] ; Luis Martínez-Sobrido | Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines |
| 000137 (2018) |
Ahmed Mostafa [Égypte] ; Elsayed M. Abdelwhab ; Thomas C. Mettenleiter ; Stephan Pleschka | Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview |
| 000207 (2018) |
Karolina Dzi Bowska [Pologne] ; El Bieta Czaczyk [Pologne] ; Dawid Nidzworski [Pologne] | Detection Methods of Human and Animal Influenza Virus—Current Trends |
| 000213 (2018) |
Sung J. Yoo [Corée du Sud] ; Taeyong Kwon [Corée du Sud] ; Young S. Lyoo [Corée du Sud] | Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure |
| 000277 (2017) |
Xiaoxiao Wang [République populaire de Chine] ; Qimei Wang [République populaire de Chine] ; Wei Cheng [République populaire de Chine] ; Zhao Yu [République populaire de Chine] ; Feng Ling [République populaire de Chine] ; Haiyan Mao [République populaire de Chine] ; Enfu Chen [République populaire de Chine] | Risk factors for avian influenza virus contamination of live poultry markets in Zhejiang, China during the 2015–2016 human influenza season |
| 000302 (2017) |
Sebastian F. Winter [Allemagne] ; Stefan F. Winter [Allemagne] | Human Dignity as Leading Principle in Public Health Ethics: A Multi-Case Analysis of 21st Century German Health Policy Decisions |
| 000303 (2017) |
R. A. M. Rafeek ; M. V. M. Divarathna ; F. Noordeen | History and current trends in influenza virus infections with special reference to Sri Lanka |
| 000307 (2017) |
Elma Tchilian ; Barbara Holzer | Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine |
| 000312 (2017) |
Wandi Zhu ; Chao Wang ; Bao-Zhong Wang | From Variation of Influenza Viral Proteins to Vaccine Development |
| 000320 (2017) |
Jian Wang [République populaire de Chine] ; Hui-Suo Yang [République populaire de Chine] ; Bing Deng [République populaire de Chine] ; Meng-Jing Shi [République populaire de Chine] ; Xiang-Da Li [République populaire de Chine] ; Qing-Gong Nian [République populaire de Chine] ; Wen-Jing Song [République populaire de Chine] ; Feng Bing [République populaire de Chine] ; Qing-Feng Li [République populaire de Chine] | Establishment and evaluation of a theater influenza monitoring platform |
| 000409 (2016) |
Patrick R. Saunders-Hastings ; Daniel Krewski | Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission |
| 000416 (2016) |
Pengfei Wei [République populaire de Chine] ; Zelang Cai [République populaire de Chine] ; Jinwen Hua [République populaire de Chine] ; Weijia Yu [République populaire de Chine] ; Jiajie Chen [République populaire de Chine] ; Kang Kang [République populaire de Chine] ; Congling Qiu [République populaire de Chine] ; Lanlan Ye [République populaire de Chine] ; Jiayun Hu [République populaire de Chine] ; Kunmei Ji [République populaire de Chine] | Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9 |
| 000428 (2016) |
Aun Lor [États-Unis] ; James C. Thomas [États-Unis] ; Drue H. Barrett [États-Unis] ; Leonard W. Ortmann [États-Unis] ; Dionisio J. Herrera Guibert [États-Unis] | Key Ethical Issues Discussed at CDC-Sponsored International, Regional Meetings to Explore Cultural Perspectives and Contexts on Pandemic Influenza Preparedness and Response |
| 000446 (2016) |
Toshihiko Matsuoka ; Tomoki Sato ; Tomoyuki Akita ; Jiturou Yanagida ; Hiroki Ohge ; Masao Kuwabara ; Junko Tanaka | High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd Immunity |
| 000455 (2016) |
Chunlong Ma [États-Unis] ; Fang Li [États-Unis] ; Rami Musharrafieh [États-Unis] ; Jun Wang [États-Unis] | Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance |
| 000527 (2015) |
Rita Czako [États-Unis] ; Kanta Subbarao [États-Unis] | Refining the approach to vaccines against influenza A viruses with pandemic potential |
| 000592 (2015) |
Mi Liu [République populaire de Chine] ; Xiang Zhao [République populaire de Chine] ; Sha Hua [République populaire de Chine] ; Xiangjun Du [États-Unis] ; Yousong Peng [République populaire de Chine] ; Xiyan Li [République populaire de Chine] ; Yu Lan [République populaire de Chine] ; Dayan Wang [République populaire de Chine] ; Aiping Wu [République populaire de Chine] ; Yuelong Shu [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] | Antigenic Patterns and Evolution of the Human Influenza A (H1N1) Virus |
| 000650 (2014) |
Michael J. Mina ; Keith P. Klugman | The role of influenza in the severity and transmission of respiratory bacterial disease |
| 000705 (2014) |
Renju S. Raj [États-Unis] ; Elizabeth A. Bonney [États-Unis] ; Mark Phillippe [États-Unis] | Influenza, Immune System, and Pregnancy |
| 000736 (2014) |
Deqiao Tian ; Tao Zheng | Comparison and Analysis of Biological Agent Category Lists Based On Biosafety and Biodefense |
| 000742 (2014) |
Heather M. Kling ; Gerard J. Nau ; Ted M. Ross ; Thomas G. Evans ; Krishnendu Chakraborty ; Kerry M. Empey ; Joanne L. Flynn | Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy |
| 000809 (2013) |
Hong Zhang ; Benjamin G. Hale ; Ke Xu ; Bing Sun [République populaire de Chine] | Viral and Host Factors Required for Avian H5N1 Influenza A Virus Replication in Mammalian Cells |
| 000829 (2013) |
Hua Yang ; Paul J. Carney ; Jessie C. Chang ; Julie M. Villanueva ; James Stevens | Structural Analysis of the Hemagglutinin from the Recent 2013 H7N9 Influenza Virus |
| 000883 (2013) |
Dennis W. Metzger ; Keer Sun | Immune Dysfunction and Bacterial Co-Infections following Influenza |
| 000925 (2013) |
Anna Mummert [États-Unis] ; Howard Weiss [États-Unis] ; Li-Ping Long [États-Unis] ; José M. Amig [Espagne] ; Xiu-Feng Wan [États-Unis] | A Perspective on Multiple Waves of Influenza Pandemics |
| 000A28 (2012) |
Jianqiang Ye [États-Unis] ; Hongxia Shao [États-Unis, République populaire de Chine] ; Daniel R. Perez [États-Unis] | Passive immune neutralization strategies for prevention and control of influenza A infections |
| 000A30 (2012) |
Madhu Khanna [Inde] ; Binod Kumar [Inde] ; Ankit Gupta [Inde] ; Prashant Kumar [Inde] | Pandemic Influenza A H1N1 (2009) Virus: Lessons from the Past and Implications for the Future |
| 000A35 (2012) |
Teresa Lambe | Novel Viral Vectored Vaccines for the Prevention of
Influenza |
| 000A50 (2012) |
Nicola Clementi ; Elena Criscuolo ; Matteo Castelli ; Nicasio Mancini ; Massimo Clementi ; Roberto Burioni | Influenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines |
| 000A56 (2012) |
Aaron Tl Lun [Australie] ; Jason Wh Wong [Australie] ; Kevin M. Downard [Australie] | FluShuffle and FluResort: new algorithms to identify reassorted strains of the influenza virus by mass spectrometry |
| 000A57 (2012) |
Jianpeng Xu [États-Unis] ; C. Todd Davis [États-Unis] ; Mary C. Christman [États-Unis] ; Pierre Rivailler [États-Unis] ; Haizhen Zhong [États-Unis] ; Ruben O. Donis [États-Unis] ; Guoqing Lu [États-Unis] | Evolutionary History and Phylodynamics of Influenza A and B Neuraminidase (NA) Genes Inferred from Large-Scale Sequence Analyses |
| 000B02 (2012) |
Ciro Esposito [Italie] ; Antimo Di Spirito [Italie] ; Nunzia Cuomo [Italie] ; Giuseppe Di Nicuolo [Italie] ; Giovanni Flaminio [Italie] ; Fabiana Altamura [Italie] ; Daniele Ambrosino [Italie] ; Federich Cantalupo [Italie] ; Caterina Costa [Italie] ; Francesca Pentimalli [États-Unis] ; Giulio Tarro [Italie, États-Unis, France] | Tracking the 2009 H1N1 influenza virus in the Italian region Campania |
| 000B15 (2012) |
R. K. Saxena [Inde] ; P. Tripathi [Inde] ; G. Rawat [Inde] | Pandemism of swine flu and its prospective drug therapy |
| 000B21 (2012) |
V. Karthick [Inde] ; V. Shanthi [Inde] ; R. Rajasekaran [Inde] ; K. Ramanathan [Inde] | In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir |
| 000B28 (2012) |
Joanna Lazniewska [Pologne] ; Katarzyna Milowska [Pologne] ; Teresa Gabryelak [Pologne] | Dendrimers—revolutionary drugs for infectious diseases |
| 000B98 (2011) |
Me Christopher ; Jp Wong | Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections |
| 000C24 (2011) |
Mary-Elise Manuell ; Mary Dawn T. Co ; Richard T. Ellison | Pandemic Influenza: Implications for Preparation and Delivery of
Critical Care Services |
| 000C26 (2011) |
Mc Christman [États-Unis] ; A. Kedwaii [États-Unis] ; J. Xu [États-Unis] ; Ro Donis [États-Unis] ; G. Lu [États-Unis] | Pandemic (H1N1) 2009 Virus Revisited: an Evolutionary Retrospective |
| 000D00 (2011) |
Seiji Kageyama | Pandemic Influenza: A Never-Ending Story |
| 000D37 (2011) |
Chantel Sloan [États-Unis] ; Martin L. Moore [États-Unis] ; Tina Hartert [États-Unis] | Impact of Pollution, Climate, and Sociodemographic Factors on Spatiotemporal Dynamics of Seasonal Respiratory Viruses |
| 000E12 (2010) |
Carlos Del Rio ; Jeannette Guarner | The 2009 Influenza A (H1N1) Pandemic: What Have We Learned in the Past 6 Months |
| 000E17 (2010) |
Hailong Guo ; Félix Santiago ; Kris Lambert ; Toru Takimoto ; David J. Topham | T Cell-Mediated Protection against Lethal 2009 Pandemic H1N1 Influenza Virus Infection in a Mouse Model ▿ |
| 000E42 (2010) |
Merrill Singer | Pathogen-pathogen interaction |
| 000E44 (2010) |
Noel J. C. Snell [Royaume-Uni] | Pandemic Influenza — Prevention and Treatment |
| 000E48 (2010) |
Yonghui Zhang [République populaire de Chine] ; Xiaojing Lin [République populaire de Chine] ; Guoqin Wang [Japon] ; Jianfang Zhou [République populaire de Chine] ; Jian Lu [République populaire de Chine] ; Honglan Zhao [République populaire de Chine] ; Fengwei Zhang [République populaire de Chine] ; Jia Wu [République populaire de Chine] ; Chunqiong Xu [République populaire de Chine] ; Ning Du [République populaire de Chine] ; Zi Li [République populaire de Chine] ; Ye Zhang [République populaire de Chine] ; Xiaoyi Wang [République populaire de Chine] ; Shengli Bi [République populaire de Chine] ; Yuelong Shu [République populaire de Chine] ; Hongning Zhou [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; Xiaobing Wu [République populaire de Chine] ; Zhihui Chen [République populaire de Chine] ; Yue Wang [République populaire de Chine] | Neuraminidase and Hemagglutinin Matching Patterns of a Highly Pathogenic Avian and Two Pandemic H1N1 Influenza A Viruses |
| 000F05 (2010) |
Alicia Sol Rzano [États-Unis] ; Jianqiang Ye [États-Unis] ; Daniel R. Pérez [États-Unis] | Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu▿ |
| 000F11 (2010) |
Seth J. Sullivan ; Robert M. Jacobson ; Walter R. Dowdle ; Gregory A. Poland | 2009 H1N1 Influenza |
| 000F37 (2010) |
A. Nicoll [Suède] | Pandemic risk prevention in European countries: role of the ECDC in preparing for pandemics |
| 000F43 (2010) |
Antoine Nougairède [France] ; Rémi N. Charrel [France] ; Didier Raoult [France] | Models cannot predict future outbreaks: A/H1N1 virus, the paradigm |
| 000F92 (2010) |
Alicia Solorzano [États-Unis] ; JIANQIANG YE [États-Unis] ; Daniel R. Perez [États-Unis] | Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu |
| 001043 (2009) |
Donna Sym [États-Unis] ; Priti N. Patel ; Gladys M. El-Chaar | Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities. |
